We produce institutional quality equity research on small/midcap healthcare and life sciences companies, making it available to all investors wherever they are based. Our goal is to bring exciting investment ideas to investors, and to assist companies in achieving their objectives.
11
Research Clients
195
Reports published
10k+
Readers in database
The @apeironbio licencing deal covers an #siRNA approach directed towards solid #tumours, further expanding @MaxCyte_info‘s diverse portfolio of clinical/commercial licences & increasing the likelihood of meaningful future milestones. Read more on $MXCT at https://www.trinitydelta.org/company-pages/
With funds of cNOK850m, @BGenBio has the resources to progress its #AXL inhibitor pipeline. Our Outlook report covers recent news for lead asset #bemcentinib with the latest #NSCLC clinical data & the potential fast route to market for COVID-19. $BGBIO https://www.trinitydelta.org/companies/bergenbio/
#FuturaMedical’s AGM statement reiterated timing of US & Europe filings for novel #erectiledysfunction device MED3000, which addresses a sizeable opportunity with OTC potential. Partnering discussions should progress once regulatory status is known. $FUM.L https://www.trinitydelta.org/companies/futura-medical/
Fresh funds of SEK378m & a potential US CERAMENT G launch in late 2020 mean @BONESUPPORT_AB's long-term growth prospects are intact, but 40+% pa revenue growth guidance from 2020 will be off a lower base due to the negative #COVID19 impact in H120. $BONEX https://www.trinitydelta.org/companies/bonesupport/
$100m equity investment by growth investor @generalatlantic provides further external validation of @HChiMed 's progress & promise. Read more on $HCM:
https://www.trinitydelta.org/companies/chi-med/
$70m (£56m) gross raised from new & current US institutional investors. @MereoBioPharma intends to use funds primarily to progress #etigilimab (anti-#TIGIT mAb) into a Phase Ib study in Q420, alongside progressing the #RareDiseases pipeline. $MPH.L $MREO
https://www.trinitydelta.org/companies/mereo-biopharma/
Please sign up here to be added to our distribution database
